|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Mobile Health Startup, QUICK Sees Opportunities for Salivary Diagnostic Platform for Diabetics, Cancer
11/16/2012 8:32:53 AM
A mobile health startup co-founded by emergency room physicians is developing a liquid- based diagnostics platform. The tests would use saliva and, in some cases, urine for rapid, noninvasive tests that could transform the way diabetics monitor ketone levels, how chemotherapy levels for cancer patients are measured, along with alcohol and marijuana detection. Dr. Ron Clark, the co-founder of QUICK, told MedCity News in a phone interview that he came up with the idea to develop a smartphone diagnostic last year, based on how frequently he was using his smartphone for various tasks around the Hospital of Central Connecticut. Colleague and co-founder Dr. David Mucci developed the diagnostic platform that uses chemistry ad physics to measure concentrations of substances in liquids. They have since added a patent lawyer and financial executive and are working with companies across the pharmaceutical and alcohol industries. The nine month old startup’s name reflects the speed the company says its diagnostic results can be determined.
|
|
|
|
|
|
|
|
|
|
|